2020 Publications

  1. Halloran KM, Parkes MD, Timofte IL, Snell GI, Westall GP, Hachem R, Kreisel D, Trulock E, Levine D, Juvet S, Keshavjee S, Jaksch P, Klepetko W, and Halloran PF. Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants. Am J Transplant 2020;20(4):954-66.
  2. Madill-Thomsen KS, Abouljoud M, Bhati C, Ciszek M, Durlik M, et al. The molecular diagnosis of rejection in liver transplant biopsies: First results of the INTERLIVER study. Am J Transplant 2020;20(8):2156-72.
  3. Madill-Thomsen K, Perkowska-Ptasińska A, Bohmig GA, Eskandary F, Einecke G, Gupta G, Halloran PF and the MMDx-Kidney Study Group. Discrepancy Analysis Comparing Molecular and Histology Diagnoses in Kidney Transplant Biopsies. Am J Transplant 2020;20(5):1341-50.
  4. Einecke G, Reeve J, Gupta G, Bohmig G, Eskandary F, Bromberg J, Budde K, Halloran PF, and the INTERCOMEX investigators. Factors associated with kidney graft survival in pure antibody-mediated rejection at the time of indication biopsy: Importance of parenchymal injury but not disease activity. Am J Transplant 2020;in press DOI: 10.1111/ajt.16161.
  5. Halloran KM, Parkes MD, Timofte I, Snell G, Westall G, Havlin J, et al. Molecular T-cell mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss. Journal of Heart and Lung Transplantation. 2020; In press https://doi.org/10.1016/j.healun.2020.08.013.
  6. Halloran PF, Bohmig G, Bromberg J, Budde K, Gupta G, Einecke G, Eskandary F, Madill-Thomsen K, Reeve J, and the INTERCOMEX investigators.Discovering novel injury features in kidney transplant biopsies associated with TCMR and donor aging. Am J Transplant 2020; In press.